These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 7939432
1. Resistance to fluoroquinolones in Pseudomonas aeruginosa and Klebsiella pneumoniae. Rydberg J, Larsson C, Miörner H. Scand J Infect Dis; 1994; 26(3):317-20. PubMed ID: 7939432 [Abstract] [Full Text] [Related]
2. [Effect of efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine to MIC values of ciprofloxacin in ciprofloxacin resistant gram-negative bacteria]. Coban AY, Bayram Z, Sezgin FM, Durupinar B. Mikrobiyol Bul; 2009 Jul; 43(3):457-61. PubMed ID: 19795621 [Abstract] [Full Text] [Related]
3. Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy. Aubert G, Pozzetto B, Dorche G. J Antimicrob Chemother; 1992 Mar; 29(3):307-12. PubMed ID: 1317371 [Abstract] [Full Text] [Related]
4. Hydrophobicity and serum sensitivity of Klebsiella pneumoniae treated with sub-MICs of quinolones. Hostacká A. Microbios; 1997 Mar; 91(368-369):137-43. PubMed ID: 9523422 [Abstract] [Full Text] [Related]
5. Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia Assessed by Minimum Inhibitory Concentrations and Time-Kill Studies. Grillon A, Schramm F, Kleinberg M, Jehl F. PLoS One; 2016 Mar; 11(6):e0156690. PubMed ID: 27257956 [Abstract] [Full Text] [Related]
6. [The activity of four fluoroquinolones against strains of Pseudomonas aeruginosa with a different sensitivity pattern to ceftazidime and imipenem]. Pascual A A, Joyanes P, Martínez-Martínez L, del Carmen Conejo M, Hernández G, Chaves J, Perea EJ. Enferm Infecc Microbiol Clin; 2001 Nov; 19(9):432-4. PubMed ID: 11709121 [Abstract] [Full Text] [Related]
14. Mutant prevention concentrations of colistin used in combination with other antimicrobial agents against Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa clinical isolates. Choi MJ, Park YK, Peck KR, Ko KS. Int J Antimicrob Agents; 2014 Nov; 44(5):475-6. PubMed ID: 25443890 [No Abstract] [Full Text] [Related]
15. The role of fluoroquinolones in the promotion of alginate synthesis and antibiotic resistance in Pseudomonas aeruginosa. Piña SE, Mattingly SJ. Curr Microbiol; 1997 Aug; 35(2):103-8. PubMed ID: 9216884 [Abstract] [Full Text] [Related]
16. Susceptibility Profile of Ceftolozane/Tazobactam and Other Parenteral Antimicrobials Against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa From US Hospitals. Sutherland CA, Nicolau DP. Clin Ther; 2015 Jul 01; 37(7):1564-71. PubMed ID: 26088525 [Abstract] [Full Text] [Related]
17. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin. Gilbert DN, Kohlhepp SJ, Slama KA, Grunkemeier G, Lewis G, Dworkin RJ, Slaughter SE, Leggett JE. Antimicrob Agents Chemother; 2001 Mar 01; 45(3):883-92. PubMed ID: 11181375 [Abstract] [Full Text] [Related]